Background Schizophrenia is a common, severe, and usually chronic disorder. Maintenance
treatment with antipsychotic drugs can prevent relapse but also causes side-effects. We …

Background Evidence of comparative benefits of long-acting injectable antipsychotics (LAIs)
versus oral antipsychotics for schizophrenia has been inconsistent across study designs …

Background Although antipsychotic maintenance treatment is widely recommended to
prevent relapse in chronic psychoses, evidence-based guidelines do not provide clear …

Background Dose reduction of antipsychotic maintenance treatment in individuals with
schizophrenia could be desirable to minimise adverse effects, but evidence for this strategy …

Background We updated our previous systematic review regarding clinical guidelines and
algorithms on antipsychotic treatment in the maintenance phase of schizophrenia (doi …

OBJECTIVE: The authors performed a systematic review and meta-analysis of studies of the
potential of new-generation antipsychotic drugs to improve adherence and decrease …

OBJECTIVE: Antipsychotic treatment strategy for the maintenance phase of schizophrenia
has been inconsistent in the literature. The purpose of this systematic review is to overview …

According to current evidence and guidelines, continued antipsychotic treatment is key for
preventing relapse in people with schizophrenia‐spectrum disorders, but evidence‐based …

Background Although continuous treatment with antipsychotics is still recommended as the
gold standard treatment paradigm for all patients with schizophrenia, some clinicians …

Background Relapse prevention with antipsychotic drugs compared with placebo in patients
with schizophrenia has not been sufficiently addressed by previous systematic reviews. We …